September 28, 2010 - Software downloaded during a routine office visit cuts the risk of inappropriate shocks by 50 percent for patients with implantable cardioverter defibrillators (ICD), according to research reported in Circulation: Journal of the American Heart Association.

September 28, 2010 – Three-year follow-up data from the HORIZONS-AMI trial presented at Transcatheter Cardiovascular Therapeutics (TCT) 2010 last week continues to show marked improvement of paclitaxel-eluting stents over bare metal stents in acute myocardial infarction (AMI).

September 28, 2010 – A fully automatic, all-in-one ultrasound cleansing and disinfection system, the Mides Transesophageal (TEE)-Care, offers ease-of-use and safe handling. It was recently introduced in Europe.

September 28, 2010 – Physicians can now determine whether a patient needs to have cardiac radionuclide imaging (RNI) by using a new smartphone app. The app, which is available for free on iPhone, BlackBerry and Android phones, gives physicians access to published criteria used to assess the need for RNI.

September 27, 2010 – A post-market study investigating a new treatment for peripheral artery disease of the superficial femoral artery (SFA) has completed enrollment.

The VIPER study, which is looking at the performance of the Gore Viabahn endoprosthesis with a heparin bioactive surface, enrolled 120 patients.

September 27, 2010 — A new plug-in quickly and easily assesses clinically relevant parameters for abdominal aortic aneurysm (AAA) stent planning.

September 27, 2010 – A premarket approval (PMA) application has been submitted for the Formula balloon-expandable stent to help treat patients suffering from renal artery stenosis. Cook Medical’s submission to the U.S. Food and Drug Administration (FDA) included data from the REFORM trial.

September 27, 2010 - Treating varicose veins with a new access kit reduces the number of steps and reduces procedure time. The .018-inch nitinol long-access wire for the VenaCure EVLT system, by AngioDynamics, reduces the number of components involved.

September 27, 2010 – Designed for productivity and versatility, the new GE Healthcare Innova 3100-IQ (Optima Edition) is a reliable, cost-effective, high-performance interventional combo lab for treating a wide variety of patients. It addresses diverse interventional cardiology and interventional radiology needs with one system. The system was unveiled at TCT 2010.

September 24, 2010 - Trial data have established the safety of a reversible PAR-1 thrombin receptor antagonist in patients with acute coronary syndrome. Results from the LANCELOT ACS trial were presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 meeting in Washington, D.C.

The study looked at atopaxar, by Eisai Pharmaceuticals.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now